References
- Floby, E., Briem, S., Terelius, Y., and Sohlenius-Sternbeck, A.- K., Use of a cocktail of probe substrates for drugmetabolizing enzymes for the assessment of the metabolic capacity of hepatocyte preparations. Xenobiotica, 34, 949- 959 (2004) https://doi.org/10.1080/00498250400017257
- Hewitt, N. J., Buhring, K-U., Dasenbrock, J., Haunschild, J., Ladstetter, B., and Utesch, D., Studies comparing in vivo:in vitro metabolism of three pharmaceutical compounds in rat, dog, monkey, and human using cryopreserved hepatocytes, microsomes, and collagen gel immobilized hepatocyte cultures. Drug Metab. Dispos., 29, 1042-1050 (2001)
- Ji, H. Y., Lee, S. S., Yoo, S. E., Kim, H., Lee, D. H., Lim, H., and Lee, H. S., In vitro metabolism of a new neuroprotective agent, KR-31543 in the human liver microsomes: Identification of human cytochrome P450. Arch. Pham. Res., 27, 239-245 (2004) https://doi.org/10.1007/BF02980112
- Kim, J. Y., Baek, M., Lee, S., Kim, S. O., Dong, M. S., Kim, B. R., and Kim, D. H., Characterization of the selectivity and mechanism of cytochrome P450 inhibition by dimethyl-4,4'- dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylate. Drug Metab. Diopos., 29, 1555-1560 (2001)
- Kim, J., Ji, H. Y., Lee, S. S., Yoo, S. E., Kim, S. O.K., Lee, D. H., Lim, H., and Lee, H. S., Metabolism of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543 in the rats using liquid chromatography/electrospray mass spectrometry. Arch. Pham. Res., 25, 664-668 (2002) https://doi.org/10.1007/BF02976941
- Kim, M. J., Kim, H., Cha, I. J., Park, J. S., Shon, J. H., Liu, K. H., and Shin, J. G., High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom., 19, 2651-2658 (2005) https://doi.org/10.1002/rcm.2110
- Lee, S., Lee, H., Yi, K. Y., Lee, B. H., Yoo, S. E., Lee, K., and Cho, N. S., 4-Substituted (benzo[b]thiophene-2-carbonyl) guanidines as novel Na+/H+ exchanger isoform-1 (NHE-1) inhibitors. Bioorg. Med. Chem. Lett., 15, 2998-3001 (2005) https://doi.org/10.1016/j.bmcl.2005.04.046
- Li, A. P., Lu, C., Brent, J. A., Pham, C., Fackett, A., Ruegg, C. E., and Silber, P. M., Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential. Chem. Biol. Interact., 121, 17-35 (1999) https://doi.org/10.1016/S0009-2797(99)00088-5
- Liu, K. H., Moon, J. K., Kang, S. H., Koo, S. J., Lee, H. S., and Kim, J. H., Identification of rat urinary and fecal metabolites of a new herbicide, pyribenzoxim. J. Agric. Food Chem., 53, 6713-6717 (2005) https://doi.org/10.1021/jf051098+
- Martinez, C., Albet, C., Agundez, J. A., Herrero, E., Carrillo, J. A., Marquez, M., Benitez, J., and Ortiz, J. A., Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists. Clin. Pharmacol. Ther., 65, 369-376 (1999) https://doi.org/10.1016/S0009-9236(99)70129-3
- Park, M. K., Liu, K. H., Lee, Y. H., Lee, Y. S., Hur, H. G., and Kim, J. H., In vitro metabolism of ethaboxam by rat liver microsomes. Agric. Chem. Biotechnol., 45, 94-98 (2002)
- Reilly, P. E., Mason, S. R., and Gillam, E. M., Differential inhibition of human liver phenacetin O-deethylation by histamine and four histamine H2-receptor antagonists. Xenobiotica, 18, 381-387 (1988) https://doi.org/10.3109/00498258809041674
- von-Moltke, L. L., Greenblatt, D. J., Duan, S. X., Harmatz, J. S., and Shader, R. I., In vitro prediction of the terfenadineketoconazole pharmacokinetic interaction. J. Clin. Pharmacol., 34, 1222-1227 (1994) https://doi.org/10.1002/j.1552-4604.1994.tb04735.x
- Wrighton, S. A., Ring, B. J., and VandenBranden, M., The use of in vitro metabolism techniques in the planning and interpretation of drug safety studies. Toxicol. Pathol., 23, 199- 208 (1995) https://doi.org/10.1177/019262339502300214